发明名称 |
METHOD OF TREATING OVARIAN AND RENAL CANCER USING ANTIBODIES AGAINST T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 1 (TIM-1) ANTIGEN |
摘要 |
The invention described herein is related to antibodies directed to the antigen TIM-1 and uses of such antibodies for the treatment of cancer (e.g., renal and ovarian cancer). In particular, there are provided fully human monoclonal antibodies directed to the antigen TIM-1. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR' s) and/or complementarity determining regions (CDR' s), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided. FlIgure I ELlSA assay of anti-TIIA-l mAbs 1.29,2.56.2,2.59.2, nd 2.45.1 agat the TIh-l antigen |
申请公布号 |
AU2013206293(A1) |
申请公布日期 |
2013.07.04 |
申请号 |
AU20130206293 |
申请日期 |
2013.06.13 |
申请人 |
CURAGEN CORPORATION |
发明人 |
POLLACK, VINCENT A.;MANSFIELD, TRACI;JEFFERS, MICHAEL E.;LAROCHELLE, WILLIAM J.;MACDOUGALL, JOHN;TSE, KAM FAI;SHENOY, SURESH G.;LICHENSTEIN, HENRI |
分类号 |
C07K16/46;A61K39/395;A61K51/00;G01N33/53 |
主分类号 |
C07K16/46 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|